The Association of Racing Commissioners International is expected to present a uniform approach on cobalt when they meet in Tampa, Florida next month, according to statements made by RCI president Ed Martin.
Speaking to the board of directors of the United States Trotting Association this past weekend, Martin said, “Regulatory veterinary staff in several jurisdictions have received complaints and/or observed instances where a cobalt administration has caused distress and colic in horses, causing cramps and muscle twitching, sweating, and pain. We are obviously concerned about the use of cobalt with the belief that it will enhance performance. But while the published science is not fully settled at what point that actually happens, we believe it is wrong to deliberately put a horse in discomfort absent a compelling medical reason to treat a serious ailment or injury. This issue is about the horse and not just about doping.”
RCI's Drug Testing Standards and Practices Committee will meet on Apr. 23 to consider options on cobalt regulatory thresholds. Recommendations from RCI science advisors, as well as other organizations such as the Racing Medication and Testing Consortium (RMTC) will be considered. In addition, Dr. Terrance S.M. Wan, the head of the Racing Laboratory and Chief Racing Chemist for the Hong Kong Jockey Cub, will be participating in the RCI meetings. Wan is the author, along with others, of a 2014 study entitled “Controlling the Misuse of Cobalt in Horses.”
Not a subscriber? Click here to sign up for the daily PDF or alerts.
